[TOVX] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
25-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -66.06%
YoY- 1.90%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 758 0 0 0 0 0 0 -
PBT -5,909 -7,016 -5,263 -2,132 -3,144 -3,192 2,812 -
Tax -424 -1,738 -13 -23 -4 -85 -8,633 -39.47%
NP -5,485 -5,591 -5,263 -2,109 -3,140 -3,173 2,850 -
Tax Rate - - - - - - 307.01% -
Total Cost 6,243 5,591 5,263 2,109 3,140 3,173 -2,850 -
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -723.61 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -8.00 -8.89 -0.40 -1.00 -1.87 -2.05 7.70 -
EPS Diluted -8.00 -8.89 -0.40 -1.00 -1.87 -2.05 7.70 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.